Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages
Ramon Edwin Caballero1,2, Simon Xin Min Dong3, Niranjala Gajanayaka4
1Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. ramon.edwin.caballero@gmail.com.
Abstract:
Macrophages serve as viral reservoirs due to their resistance to apoptosis and HIV-cytopathic effects. We have previously shown that inhibitor of apoptosis proteins (IAPs) confer resistance to HIV-Vpr-induced apoptosis in normal macrophages. Herein, we show that second mitochondrial activator of caspases (SMAC) mimetics (SM) induce apoptosis of monocyte-derived macrophages (MDMs) infected in vitro with a R5-tropic laboratory strain expressing heat stable antigen, chronically infected U1 cells, and ex-vivo derived MDMs from HIV-infected individuals. To understand the mechanism governing SM-induced cell death, we show that SM-induced cell death of primary HIV-infected macrophages was independent of the acquisition of M1 phenotype following HIV infection of macrophages. Instead, SM-induced cell death was found to be mediated by IAPs as downregulation of IAPs by siRNAs induced cell death of HIV-infected macrophages. Moreover, HIV infection caused receptor interacting protein kinase-1 (RIPK1) degradation which in concert with IAP1/2 downregulation following SM treatment may result in apoptosis of macrophages. Altogether, our results show that SM selectively induce apoptosis in primary human macrophages infected in vitro with HIV possibly through RIPK1. Moreover, modulation of the IAP pathways may be a potential strategy for selective killing of HIV-infected macrophages in vivo.
Insights
Second mitochondrial activator of caspases (SMAC) mimetics induce apoptosis in HIV-infected macrophages by targeting inhibitor of apoptosis proteins (IAPs). This suggests IAP pathway modulation as a strategy to eliminate viral reservoirs.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Macrophages are crucial viral reservoirs for HIV due to resistance to apoptosis.
- Inhibitor of apoptosis proteins (IAPs) contribute to this resistance against HIV-induced cell death.
Purpose of the Study:
- To investigate the mechanism of SMAC mimetic-induced apoptosis in HIV-infected macrophages.
- To explore the role of IAPs and RIPK1 in this process.
Main Methods:
- Treatment of HIV-infected monocyte-derived macrophages (MDMs) with SMAC mimetics (SM).
- Downregulation of IAPs using siRNAs.
- Analysis of RIPK1 degradation and M1 phenotype acquisition.
Main Results:
- SMAC mimetics induced apoptosis in HIV-infected MDMs, including ex-vivo samples.
- SM-induced cell death was IAP-dependent and independent of M1 phenotype.
- HIV infection led to RIPK1 degradation, potentially contributing to SM-induced apoptosis.
Conclusions:
- SMAC mimetics selectively induce apoptosis in HIV-infected macrophages, possibly via RIPK1.
- Modulating IAP pathways offers a potential therapeutic strategy for targeting HIV reservoirs.


